Free Trial

Vericel (VCEL) Stock Price, News & Analysis

Vericel logo
$41.60 -0.95 (-2.23%)
Closing price 04:00 PM Eastern
Extended Trading
$41.62 +0.02 (+0.05%)
As of 04:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Vericel Stock (NASDAQ:VCEL)

Key Stats

Today's Range
$41.45
$43.51
50-Day Range
$37.92
$45.70
52-Week Range
$37.39
$63.00
Volume
449,999 shs
Average Volume
416,382 shs
Market Capitalization
$2.09 billion
P/E Ratio
1,387.13
Dividend Yield
N/A
Price Target
$61.14
Consensus Rating
Buy

Company Overview

Vericel Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
58th Percentile Overall Score

VCEL MarketRank™: 

Vericel scored higher than 58% of companies evaluated by MarketBeat, and ranked 462nd out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Vericel has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Vericel has only been the subject of 2 research reports in the past 90 days.

  • Read more about Vericel's stock forecast and price target.
  • Earnings Growth

    Earnings for Vericel are expected to grow by 214.29% in the coming year, from $0.14 to $0.44 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vericel is 1,387.13, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.87.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vericel is 1,387.13, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.22.

  • Price to Book Value per Share Ratio

    Vericel has a P/B Ratio of 7.03. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Vericel's valuation and earnings.
  • Percentage of Shares Shorted

    9.72% of the float of Vericel has been sold short.
  • Short Interest Ratio / Days to Cover

    Vericel has a short interest ratio ("days to cover") of 9.1.
  • Change versus previous month

    Short interest in Vericel has recently increased by 0.43%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Vericel does not currently pay a dividend.

  • Dividend Growth

    Vericel does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.72% of the float of Vericel has been sold short.
  • Short Interest Ratio / Days to Cover

    Vericel has a short interest ratio ("days to cover") of 9.1.
  • Change versus previous month

    Short interest in Vericel has recently increased by 0.43%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Vericel has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.88 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Vericel this week, compared to 6 articles on an average week.
  • Search Interest

    3 people have searched for VCEL on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Vericel insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,040,966.00 in company stock.

  • Percentage Held by Insiders

    Only 7.20% of the stock of Vericel is held by insiders.

  • Read more about Vericel's insider trading history.
Receive VCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vericel and its competitors with MarketBeat's FREE daily newsletter.

VCEL Stock News Headlines

Vericel Corporation: Moving From Sell To Neutral
This Crypto Is Set to Explode in January
Free summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this means and how everyday investors like you can position themselves to potentially profit. The timing couldn't be more critical
See More Headlines

VCEL Stock Analysis - Frequently Asked Questions

Vericel's stock was trading at $54.91 at the start of the year. Since then, VCEL stock has decreased by 24.2% and is now trading at $41.60.
View the best growth stocks for 2025 here
.

Vericel Corporation (NASDAQ:VCEL) released its quarterly earnings results on Thursday, May, 8th. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by $0.14. Vericel's quarterly revenue was up 2.6% on a year-over-year basis.
Read the conference call transcript
.

Shares of VCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vericel investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Adobe (ADBE), Palo Alto Networks (PANW) and Netflix (NFLX).

Company Calendar

Last Earnings
5/08/2025
Today
7/01/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VCEL
Employees
300
Year Founded
1989

Price Target and Rating

Average Stock Price Target
$61.14
High Stock Price Target
$67.00
Low Stock Price Target
$51.00
Potential Upside/Downside
+47.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

Trailing P/E Ratio
1,387.13
Forward P/E Ratio
297.14
P/E Growth
N/A
Net Income
$10.36 million
Pretax Margin
1.31%

Debt

Sales & Book Value

Annual Sales
$237.22 million
Cash Flow
$0.31 per share
Price / Cash Flow
136.16
Book Value
$5.92 per share
Price / Book
7.03

Miscellaneous

Free Float
46,718,000
Market Cap
$2.09 billion
Optionable
Optionable
Beta
1.32

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:VCEL) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners